SELECTIVE MODE OF ACTION OF THE DOPAMINE D-2 RECEPTOR ANTAGONIST SULPIRIDE IN BEHAVIORAL PHARMACOLOGICAL MODELS

被引：0
|
作者：
LJUNGBERG, T [1 ]
机构：
[1] KAROLINSKA INST,DEPT PHARMACOL,S-10401 STOCKHOLM 60,SWEDEN
来源：
BEHAVIOURAL BRAIN RESEARCH | 1987年 / 26卷 / 2-3期
关键词：
D O I：
10.1016/0166-4328(87)90206-3
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [11] DOPAMINE D-2, ANTAGONIST REMOXIPRIDE ACTS IN-VIVO ON A SUBPOPULATION OF DOPAMINE D-2, RECEPTORS
    OGREN, SO
    ROSEN, L
    FUXE, K
    NEUROSCIENCE, 1994, 61 (02) : 269 - 283
  • [12] PENTAZOCINE-LIKE DISCRIMINATIVE STIMULUS EFFECTS OF MORPHINE ARE BLOCKED BY THE DOPAMINE D-1 ANTAGONIST SCH23390, BUT NOT BY THE DOPAMINE D-2 ANTAGONIST SULPIRIDE
    UKAI, M
    HIRAIWA, E
    KAMEYAMA, T
    BRAIN RESEARCH, 1991, 541 (01) : 146 - 148
  • [13] Antagonist binding to the D-2 dopamine receptor and the role of conserved serine residues
    Coley, C
    Woodward, R
    Strange, PG
    Naylor, LH
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P276 - P276
  • [14] A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride
    Martelle, Jennifer L.
    Nader, Michael A.
    CNS NEUROSCIENCE & THERAPEUTICS, 2008, 14 (03) : 248 - 262
  • [15] Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction
    Xi, Zheng-Xiong
    Gardner, Eliot L.
    CNS DRUG REVIEWS, 2007, 13 (02): : 240 - 259
  • [16] BEHAVIORAL PHARMACOLOGY OF DOPAMINE RECEPTOR SUBTYPES - D-2 RECEPTORS SELECT MODE OF BEHAVIORAL EXPRESSION WHILE D-1 RECEPTORS CONTROL INTENSITY OF MODE SELECTED
    WADDINGTON, JL
    MOLLOY, AG
    MASHURANO, M
    PSYCHOPHARMACOLOGY, 1986, 89 (04) : S37 - S37
  • [17] THE CHARACTERIZATION OF IBF AS A NEW SELECTIVE DOPAMINE D-2 RECEPTOR IMAGING AGENT
    KUNG, MP
    KUNG, HF
    BILLINGS, J
    YANG, YY
    MURPHY, RA
    ALAVI, A
    JOURNAL OF NUCLEAR MEDICINE, 1990, 31 (05) : 648 - 654
  • [18] Characterization of unconditioned behavioral effects of dopamine D-3/D-2 receptor agonists
    GeterDouglass, B
    Katz, JL
    Alling, K
    Acri, JB
    Witkin, JM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 283 (01): : 7 - 15
  • [19] Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist
    Merchant, KM
    Gill, GS
    Harris, DW
    Huff, RM
    Eaton, MJ
    Lookingland, K
    Lutzke, BS
    Mccall, RB
    Piercey, MF
    Schreur, PJKD
    Sethy, VH
    Smith, MW
    Svensson, KA
    Tang, AH
    Vonvoigtlander, PF
    Tenbrink, RE
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 279 (03): : 1392 - 1403
  • [20] LOSS OF D-1/D-2 DOPAMINE-RECEPTOR SYNERGISMS FOLLOWING REPEATED ADMINISTRATION OF D-1 OR D-2 RECEPTOR-SELECTIVE ANTAGONISTS - ELECTROPHYSIOLOGICAL AND BEHAVIORAL-STUDIES
    HU, XT
    WHITE, FJ
    SYNAPSE, 1994, 17 (01) : 43 - 61
12345